Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Soft-Tissue Sarcomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03793361
What this trial is testing

Phase II Study of Regorafenib as Maintenance Therapy

Who this might be right for
Metastatic Soft Tissue Sarcoma
Centre Oscar Lambret 127
Testing effectiveness (Phase 2)Study completedNCT00405327
What this trial is testing

A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation

Who this might be right for
SarcomaNeuroblastomaWilm's Tumor
University of Michigan Rogel Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT00802880
What this trial is testing

Dacarbazine for Metastatic Soft Tissue and Bone Sarcoma

Who this might be right for
Sarcoma
Washington University School of Medicine 80
Early research (Phase 1)Study completedNCT02192346
What this trial is testing

Α-TEA in Advanced Cancer

Who this might be right for
Metastatic CarcinomaMetastatic SarcomaMetastatic Lymphoma
Providence Health & Services 17
Not applicableUnknownNCT00072488
What this trial is testing

Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma

Who this might be right for
LymphomaNeuroblastomaSarcoma
American College of Radiology Imaging Network 226
Testing effectiveness (Phase 2)UnknownNCT03063983
What this trial is testing

Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic Osteosarcoma

Who this might be right for
Osteosarcoma
Grupo de Apoio ao Adolescente e a Crianca com Cancer 158
Not applicableStudy completedNCT01586104
What this trial is testing

Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases

Who this might be right for
Adult RhabdomyosarcomaLung MetastasesMetastatic Ewing Sarcoma+9 more
Ann & Robert H Lurie Children's Hospital of Chicago 20
Not applicableStudy completedNCT01807052
What this trial is testing

Biomarker Expression in Tissue Samples From Patients With Bone Sarcomas

Who this might be right for
Localized OsteosarcomaMetastatic OsteosarcomaRecurrent Osteosarcoma
Children's Oncology Group 34
Testing effectiveness (Phase 2)UnknownNCT00036712
What this trial is testing

Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+9 more
Medical College of Wisconsin 80
Early research (Phase 1)Study completedNCT00720174
What this trial is testing

Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma

Who this might be right for
Adult AngiosarcomaAdult Desmoplastic Small Round Cell TumorAdult Epithelioid Sarcoma+32 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT01343043
What this trial is testing

A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma

Who this might be right for
Neoplasms
GlaxoSmithKline 50
Early research (Phase 1)Study completedNCT02398058
What this trial is testing

Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS)

Who this might be right for
Soft Tissue SarcomaBone Tumor
Italian Sarcoma Group 50
Early research (Phase 1)Looking for participantsNCT04999761
What this trial is testing

AB122 Platform Study

Who this might be right for
Advanced or Metastatic Solid TumorPancreatic Ductal AdenocarcinomaColorectal Cancer+6 more
Taiho Pharmaceutical Co., Ltd. 917
Not applicableEnded earlyNCT03959033
What this trial is testing

Patient Reported Outcome Measures (PROMs) With Trabectedin

Who this might be right for
SarcomaLiposarcomaLeiomyosarcoma
University of Leeds 7
Early research (Phase 1)Looking for participantsNCT04222413
What this trial is testing

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Pancreatic CancerPediatric Solid Tumor+3 more
National Cancer Institute (NCI) 116
Testing effectiveness (Phase 2)UnknownNCT05448820
What this trial is testing

YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma

Who this might be right for
Advanced SarcomaMetastatic SarcomaSoft Tissue Sarcoma
Tracon Pharmaceuticals Inc. 15
Testing effectiveness (Phase 2)Study completedNCT01782313
What this trial is testing

A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas

Who this might be right for
Recurrent Adult Soft Tissue SarcomaStage III Adult Soft Tissue SarcomaStage IV Adult Soft Tissue Sarcoma
Northwestern University 58
Testing effectiveness (Phase 2)WithdrawnNCT05042934
What this trial is testing

Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma

Who this might be right for
Metastatic Ewing SarcomaRecurrent Ewing Sarcoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT02601209
What this trial is testing

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

Who this might be right for
High Grade SarcomaMetastatic LeiomyosarcomaMetastatic Malignant Peripheral Nerve Sheath Tumor+16 more
National Cancer Institute (NCI) 151
Testing effectiveness (Phase 2)Active Not RecruitingNCT04458922
What this trial is testing

Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma

Who this might be right for
Central Chondrosarcoma, Grade 2Central Chondrosarcoma, Grade 3Dedifferentiated Chondrosarcoma+3 more
National Cancer Institute (NCI) 27
Next Page